Listings on Hong Kong’s HKEx stock exchange could raise between $54bn and $60bn over the course of 2021 as companies queue up to raise investment to fund their business development plans and the former British protectorate cements its position as the capital market of choice for the booming biotechnology sector. According to PwC Hong Kong, new economy and US listed Chinese companies are expected to remain the main drivers of a surge which could see HKEx regain its crown as the top global IPO fundraising market and surpass the precious record set in 2010. “Supported by a healthy pipeline, 2021 will be a great year for the Hong Kong IPO market.,” Eddie Wong, PwC Hong Kong Capital Markets Services partner said. “We are confident that the total IPO funds raised willl hit a record high.”